These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15126503)

  • 1. Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5.
    Yun J; Tomida A; Andoh T; Tsuruo T
    J Biol Chem; 2004 Jul; 279(30):31296-303. PubMed ID: 15126503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.
    Yun J; Kim YI; Tomida A; Choi CH
    Biochem Biophys Res Commun; 2009 Nov; 389(1):5-9. PubMed ID: 19695223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic expression of human topoisomerase IIalpha fragments and etoposide resistance in mammalian cells.
    Ernst AI; Soltermann A; Sigrist JA; Widmer L; Gasser SM; Stahel RA
    Int J Cancer; 2000 Oct; 88(1):99-107. PubMed ID: 10962446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.
    Burger-Kentischer A; Finkelmeier D; Thiele M; Schmucker J; Geiger G; Tovar GE; Bernhagen J
    FEBS Lett; 2005 Mar; 579(7):1693-701. PubMed ID: 15757663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAB1/CSN5 interacts with the GAL4 DNA binding domain: a note of caution about two-hybrid interactions.
    Nordgård O; Dahle Ø; Andersen TØ; Gabrielsen OS
    Biochimie; 2001 Oct; 83(10):969-71. PubMed ID: 11728635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells.
    Chen MC; Chen CH; Chuang HC; Kulp SK; Teng CM; Chen CS
    Hepatology; 2011 Jan; 53(1):148-59. PubMed ID: 21254166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction between human topoisomerase IIalpha and retinoblastoma protein.
    Bhat UG; Raychaudhuri P; Beck WT
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7859-64. PubMed ID: 10393912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding activity of rat DNA topoisomerase II α C-terminal domain contributes to efficient DNA catenation in vitro.
    Kawano S; Kato Y; Okada N; Sano K; Tsutsui K; Tsutsui KM; Ikeda S
    J Biochem; 2016 Mar; 159(3):363-9. PubMed ID: 26527691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of catalytic activity and nucleolar localization of rat DNA topoisomerase IIα through its C-terminal domain.
    Yasuda K; Kato Y; Ikeda S; Kawano S
    Genes Genet Syst; 2021 Mar; 95(6):291-302. PubMed ID: 33551432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
    Kim HD; Tomida A; Ogiso Y; Tsuruo T
    J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics of DNA topoisomerase IIalpha in living cells.
    Daum JR; Mo YY; Gorbsky GJ
    Methods Mol Biol; 2009; 582():233-44. PubMed ID: 19763954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
    Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
    Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA topoisomerase IIα controls replication origin cluster licensing and firing time in Xenopus egg extracts.
    Gaggioli V; Le Viet B; Germe T; Hyrien O
    Nucleic Acids Res; 2013 Aug; 41(15):7313-31. PubMed ID: 23757188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation.
    Kim BC; Lee HJ; Park SH; Lee SR; Karpova TS; McNally JG; Felici A; Lee DK; Kim SJ
    Mol Cell Biol; 2004 Mar; 24(6):2251-62. PubMed ID: 14993265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
    Mo YY; Beck WT
    Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIα.
    Seol Y; Gentry AC; Osheroff N; Neuman KC
    J Biol Chem; 2013 May; 288(19):13695-703. PubMed ID: 23508957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.
    Singh R; Winn LM
    Mutat Res; 2008 Oct; 645(1-2):33-8. PubMed ID: 18778717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATF is important to late S phase-dependent regulation of DNA topoisomerase IIalpha gene expression in HeLa cells.
    Son MY; Kim TJ; Kweon KI; Park JI; Park C; Lee YC; No Z; Ahn JW; Yoon WH; Park SK; Lim K; Hwang BD
    Cancer Lett; 2002 Oct; 184(1):81-8. PubMed ID: 12104051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.